Spelling suggestions: "subject:"dioxo MP 14"" "subject:"dioxa MP 14""
1 |
Pharmaceutical formulation and in-vitro testing of Dioxy MP 14 (stabilised chlorine dioxide) against mycobacteria tuberculosisMavu, Daniel Muleya January 2011 (has links)
Magister Pharmaceuticae - MPharm / This study was based on Dioxy MP 14 (DMP), a brand of stabilized chlorine dioxide (SCD). The active pharmaceutical ingredient (API) of DMP is chlorine dioxide (CD) which is a potent oxidant and biocide. These properties have proved invaluable for various applications. The main goals of this study were: to evaluate the effectiveness of DMP for disinfecting Mycobateria tuberculosis (TB) contaminated medical instruments, devices, floors and surfaces; to investigate the stability of DMP; and to explore possibilities for medical application of DMP. Evaluation of disinfectant activity of DMP on TB was performed using the spectrophotometric method, a modification of the European suspension test, EN 14348. M. bovis BCG was employed as surrogate in this test. Results were as follows: The minimum inhibitory concentration (MIC₉₀) = 12.5 ppm; the minimum bactericidal concentration (MBC) = 15.4 ppm; the Mycobactericidal Effect (ME) = 8.8log reduction; and the minimum inhibitory concentration (MIC₉₀) x minimum exposure time (CT) = 12.5 ppm.s. The long term stability study of DMP was performed by monitoring the rate of degradation of DMP stored in the fridge (2-8 °C), in the oven (40 °C), and under ambient conditions (15-30 °C). Analytical methods of assessing DMP concentration was by Iodometric titration method. The shelf life of DMP stored in a transparent bottle at room temperature was 9.8 weeks, as opposed to 52.7 weeks when stored in an amber colored reagent bottle at the same temperature. Both oven samples had an expiry date of about 20 weeks and the fridge samples about 70 weeks. Foam formulations for a vaginal douche (VGD), mouth rinse (MRF), and foot/sit bubble bath (F/SBB)], were developed in the laboratory. DMP and the formulated concentrate were designed to be mixed just prior to administration. During foam evaluation studies, a mechanical overhead stirrer was used to generate foam. Foamability was assessed by quantifying the amount of foam generated. The stability of foams were assessed by: 1) determining the rate of foam decay and the rate of foam drainage observed concurrently from foam loaded in a measuring cylinder; and 2) determining the life span of single bubbles of each foam system i.e. the bubble breaking time (BBT). The density of each foam system was also determined. Potentiometric acid base titration was used to select suitable adjuster alkali, and to show the benefits of employing a buffer. Concentrate development was initiated by a simple mixture of all the ingredients followed by stirring and observing the deviations from desired quality attributes of the product. The subsequent five processes were improvements designed to circumvent the shortcomings of the initial procedure to arrive at the optimized method E. Prototype formulations were employed to optimize excipient quantities to eventually arrive at an optimized master formula. In foam evaluation, it was found that sodium lauryl sulphate/ammonium lauryl sulphate/cocoamidopropyl betaine/cetostearyl alcohol (SLS/ALS/CAPB/CSA) foam system was the most appropriate to use in the formulation. NaOH was selected as the adjuster solution and KHP as the buffer. The dosage formula (DF) of the VGD and F/SBB was determined to be MDF = 5 ml of 50 ppm DMP + 5 ml concentrate + 40 ml water = 50 ml and that of MRF as MDF = 19 ml diluted concentrate + 1 ml of 50 ppm DMP. In conclusion, DMP was found to be a highly effective disinfectant against Mycobacteria. DMP has reasonable shelf life if stored appropriately. Pharmaceutical formulation from DMP was found to be delicate due to the narrow pH window of DMP stability, but is feasible.
|
2 |
The use of dioxy MP 14 (stabilized aqueous chlorine dioxide) to control environmental airborne microorganismsMbamalu, Oluchi Nneka January 2009 (has links)
Magister Pharmaceuticae - MPharm / Dioxy MP 14 is a locally developed form of stabilized chlorine dioxide in an aqueous medium. It has all the sanitizing properties of chlorine dioxide gas, a neutral compound of chlorine in the +IV oxidation state, which has been used extensively as a non-toxic sterilizing agent with various applications. In this study, Dioxy MP14 was tested in a commercial chicken pen to determine its effectiveness as an environmental sanitizing agent. Control of environmental microbes in a chicken pen is important to ensure healthy birds and optimum egg production. The biocide was introduced via an overhead misting system with a variable dosing pump at various daily frequencies.The effectiveness of environmental microorganism control was determined with air settle plates. The health and performance of the chickens were evaluated and compared to chickens in a control pen.The results show a decrease in airborne microbial load in the treated pen. Better egg production and lower mortality of the chickens in the treated pen compared to the control pen, indicate effective environmental microbial control was achieved with a residual 7.46 ppm Dioxy MP 14 at a daily dose given for 5 minutes every 2 hours.This study was a pilot study, with encouraging results, for an extended study to investigate the feasibility of introducing Dioxy MP 14 through a misting system in a clinical environment (clinics and hospitals) to control airborne pathogens like Mycobacterium tuberculosis thereby reducing the infection risks for clinical workers and medical staff.
|
Page generated in 0.0421 seconds